Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022
ACS Infectious Diseases · 12.05.2023 · 9 (5) · 1046-1055
DOI: 10.1021/acsinfecdis.3c00081 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, online erschienen am 21.04.2023. Verfasst von Nicola Caldwell und 20 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee …. Hauptthemen laut MEDLINE: Schistosomiasis, Anthelmintics. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, World Health Organization.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee DD1 5EH, United Kingdom.
- Global Health Institute of Merck, a subsidiary of Merck KGaA, Darmstadt, Germany, Ares Trading S.A., Route de Crassier 1, 1262 Eysins, Switzerland.
- Department of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom.
- Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, MC0657, La Jolla, California 92093, United States.
- Department of Pharmacology, UT Southwestern Medical Center, Forest Park Road, Dallas, Texas 75235, United States.
- Department of Infectious Disease Epidemiology, Bernhard Nocht Institute of Tropical Medicine, 20359 Hamburg, Germany.
ORCID-Profile: Nicola Caldwell, Beatriz Baragaña, Conor R Caffrey, Karl F Hoffmann, Case W McNamara, Gilda Padalino, Kevin D Read, Thomas Spangenberg, Ian H Gilbert
Förderung
- Wellcome Trust
- World Health Organization
Zitieren
APA
Caldwell, N., Afshar, R., Baragaña, B., Bustinduy, A. L., Caffrey, C. R., Collins, J. J., Fusco, D., Garba, A., Gardner, M., Gomes, M., Hoffmann, K. F., Hsieh, M., Lo, N. C., McNamara, C. W., Nono, J. K., Padalino, G., Read, K. D., Roestenberg, M., Spangenberg, T., …, & Gilbert, I. H. (2023). Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022. ACS Infectious Diseases, 9(5), 1046-1055. https://doi.org/10.1021/acsinfecdis.3c00081
Vancouver
Caldwell N, Afshar R, Baragaña B, Bustinduy AL, Caffrey CR, Collins JJ, et al. Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022. ACS Infectious Diseases. 2023;9(5):1046-1055. doi:10.1021/acsinfecdis.3c00081
BibTeX
@article{Caldwell2023,
author = {Caldwell, Nicola and Afshar, Rana and Baragaña, Beatriz and Bustinduy, Amaya L and Caffrey, Conor R and Collins, James J and Fusco, Daniela and Garba, Amadou and Gardner, Mark and Gomes, Mireille and Hoffmann, Karl F and Hsieh, Michael and Lo, Nathan C and McNamara, Case W and Nono, Justin Komguep and Padalino, Gilda and Read, Kevin D and Roestenberg, Meta and Spangenberg, Thomas and Specht, Sabine and Gilbert, Ian H},
title = {Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022},
journal = {ACS Infectious Diseases},
year = {2023},
volume = {9},
number = {5},
pages = {1046--1055},
doi = {10.1021/acsinfecdis.3c00081}
}
EUVIMED